<DOC>
	<DOCNO>NCT02159001</DOCNO>
	<brief_summary>Electroconvulsive therapy ( ECT ) one old neuromodulation treatment still use psychiatry . Only case report open label non-randomized study publish ECT clozapine-resistant schizophrenia patient . The purpose trial study efficacy cognitive effect add-on ECT treatment ( 10-course ) schizophrenia patient take clozapine .</brief_summary>
	<brief_title>Electroconvulsive Therapy Clozapine-resistant Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>diagnosis schizophrenia schizoaffective disorder treatmentresistant clozapine age 18 64 year capacity willingness give informed consent serious somatic illness progressive neurological illness , recent brain damage sequela serious brain damage ECT le 3 month prior trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>clozapine</keyword>
	<keyword>ECT</keyword>
	<keyword>PANSS</keyword>
	<keyword>schizoaffective disorder</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>treatment</keyword>
</DOC>